Hire Bhapinder Singh Grover, a pharma consultant specializing in FDA Inspections, Pharmaceutical Manufacturing, Pharmaceutical Quality and Sterile Manufacturing. See services offered, experience summary, and connect via apicule.
Based in: India
Willing to work in: Global
Consultant Type: Independent Consultant
Expertise summary: Bhapinder Singh Grover is a pharmaceutical GxP consultant with 35+ years of experience across quality control, quality assurance, validation, compliance, and microbiology in both sterile and non-sterile pharmaceutical manufacturing. His background includes senior leadership roles in QA/QC, setup of quality management systems in greenfield projects, extensive vendor-audit exposure, successful hosting of major global inspections, and deep expertise in aseptic processing, media fills, investigations, CAPA, cleaning validation, process validation, and facility and utility qualification.
Bhapinder supports aseptic manufacturing through deep experience in sterile dosage forms, sterile APIs, sterility assurance, contamination control, environmental monitoring, smoke studies, and aseptic process simulation. His profile shows direct expertise in sterile facilities, media fills, sterilization processes, and microbiology-led quality assurance, making him a strong fit for organizations that need practical support in strengthening aseptic operations and improving compliance in sterile environments.
Bhapinder supports cleaning validation through preparation and review of validation programs, protocols, and reports for regulated pharmaceutical manufacturing sites. His profile explicitly lists cleaning validation as one of his consulting strengths, along with broader experience in investigations, CAPA, microbiology, qualification, and risk-based compliance, which gives him a strong base for helping companies improve cleaning-validation execution and inspection readiness.
Bhapinder supports FDA-483 response and remediation through regulatory observation review, compliance-gap assessment, root cause analysis, CAPA planning, and implementation-focused remediation. His experience includes preparation of responses to regulatory and customer audit observations, remediation of compliance gaps, and successful support during stringent inspections such as USFDA, MHRA, EU-GMP, WHO-PQ, TGA, and ANVISA. He helps companies convert audit findings into practical quality improvements that strengthen inspection readiness and reduce recurrence.
Bhapinder supports GMP training through practical, experience-based sessions on GMP, microbiology, quality systems, data integrity, aseptic processing, environmental monitoring, sterility assurance, validation, and cleanroom behaviors. His resume also reflects long senior-management experience and technical teaching exposure, which supports his ability to train teams not only on compliance requirements but also on their execution in real manufacturing environments.
Bhapinder supports media fill simulation through direct experience in aseptic process simulation for sterile dosage forms, sterile APIs, and injectable operations. His profile explicitly includes aseptic processing, media fills, trend analysis, investigation support, and sterility assurance planning, making this one of his strongest specialist services. He helps sterile manufacturers improve the robustness of media fill programs and align them more closely with regulatory expectations and practical aseptic process behavior.
Bhapinder supports mock FDA inspections through realistic audit simulation, stringent-regulatory gap assessment, and remediation planning. His profile shows repeated success hosting and preparing for USFDA and other global inspections, along with explicit consulting services around mock audits and gap assessments for stringent regulatory inspections. He helps organizations identify weaknesses before actual inspections and improve documentation, systems, and shop-floor preparedness.
Bhapinder supports process validation through experience in validation strategy, protocol development, review of reports, continued process verification, and protocol preparation for solid and liquid oral dosage forms. His expertise spans both sterile and non-sterile environments, allowing him to support manufacturers in building practical validation programs that are scientifically sound, compliant, and operationally workable.
Bhapinder supports third-party GMP audits through extensive audit exposure across drug products, APIs, excipients, packaging materials, and vendor operations in India and overseas. His resume states that he conducted more than 100 audits of drug substances, drug products, and packaging-material vendors, making this a highly credible and well-grounded service area. He helps organizations assess external partners more effectively and strengthen supply-chain compliance through practical and risk-focused auditing.
